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SUPRAUMBILICAL SKIN RASH AND FAT NECROSIS
AFTER TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION: A CASE REPORT
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We report the case of a 63-year-old female who had chronic hepatitis C and who was diagnosed with
hepatocellular carcinoma. Hepatic angiography showed one visible and tortuous falciform artery arising
as the terminal branch of the left hepatic artery. Transcatheter arterial chemoembolization (TACE) was
performed via the left hepatic artery. The patient developed supraumbilical skin rash with local tenderness
on the following day. After supportive treatment by a dermatologist, the skin rash subsided gradually
with sequelae of irregular skin surface and one small subcutaneous nodule. Skin biopsy of the lesion 1
year later showed fat necrosis with foreign body reaction and fibrosis. We discuss this rare complication
of TACE and review the literature.
Key Words: falciform artery, transcatheter arterial chemoembolization,
hepatocellular carcinoma
(Kaohsiung J Med Sci 2004;20:36–40)
Received: May 27, 2003       Accepted: September 2, 2003
Address correspondence and reprint requests to: Dr. Ding-Kwo Wu,
Department of Medical Imaging, Kaohsiung Medical University, 100
Shih-Chuan 1st Road, Kaohsiung 807, Taiwan.
E-mail: cc@med-assn.org.tw
© 2004 Elsevier. All rights reserved.
Transcatheter arterial chemoembolization (TACE) has been
widely used to treat malignant liver tumors. By interrupting
the arterial supply, chemoembolization deprives the tumor
of its major nutrient source and allows for prolonged re-
tention of tumoricidal agent within the tumor, resulting in
extensive tumor necrosis. A wide spectrum of compli-
cations after TACE have been reported [1,2]. A rare compli-
cation of TACE is supraumbilical skin rash caused by
the flow of the chemotherapeutic agent into the hepatic
falciform artery (HFA). We report such a case and review
the literature.
CASE PRESENTATION
A 63-year-old female patient with chronic hepatitis C
received regular follow-up at Chia-Yi Christian Hospital,
Taiwan, for 20 years. She had previously undergone
hysterectomy for uterine myoma and focal excision for bi-
lateral breast fibromas. A liver nodule about 2 × 2 cm at S4
was discovered on sonography, computerized tomography
(CT) and magnetic resonance imaging (MRI) at Chia-Yi
Christian Hospital in October 2001. She was referred to our
institution 2 months later. Under the impression of hepa-
tocellular carcinoma, angiography was arranged for further
survey and treatment. Celiac arteriography showed a small
hypervascular nodule fed by the left hepatic artery. One
obvious falciform artery arising from the left hepatic artery
was also identified (Figure 1). TACE was carried out via
the left hepatic artery with infusion of 4 mL of lipiodol
(Lipiodol Ultra-Fluide, Guerbet, Aulnay-sous-Bois, France)
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mixed with 30 mg of epirubicin and 6 mg of mitomycin-C,
followed by arterial feeder devascularization using gelatin
sponge (Gelfoam, Pharmacia and Upjohn, Kalamazoo, MI,
USA). The falciform artery could not be left out of the
arterial chemoembolization due to technical difficulty.
The next day, after TACE, the patient complained of
abdominal pain; physical examination revealed a supra-
umbilical skin induration (Figure 2). The induration was
associated with tenderness and measured about 10 × 13 cm.
No fever was noted. The skin lesions were confined mainly
to the left of the midline and below the xiphoid. One month
after TACE, CT showed remarkable thickening of the supra-
umbilical skin, with increased density and infiltration of
associated subcutaneous fat (Figure 3A). The connective
tissue along the tract of the falciform artery was expanded
with infiltration (Figure 3B). Oral nonsteroidal anti-
inflammatory drugs and focal infrared laser treatment were
given. The skin rash and focal tenderness over the
supraumbilical region subsided gradually. Three months
later, CT showed that the lesion in the subcutaneous fat
layer was smaller (Figure 3C). The subcutaneous nodule
measured about 2 × 2.6 × 2.7 cm 1 year later (Figure 3D). Skin
biopsy showed fat necrosis with foreign body reaction and
fibrosis.
DISCUSSION
The HFA arises as one or two small terminal branches of the
left or middle hepatic artery [3]. Delayed and persistent
opacification of the HFA on hepatic angiograms, caused by
its slow blood flow, is considered the key to its angiographic
identification [4]. Anatomically, the HFA runs within the
falciform ligament and distributes itself around the
umbilicus. A review of published papers shows incidences
of angiography-visible falciform arteries ranging from 2%
to 67.2% [3,5,6]. At our institution, a retrospective study of
100 cases estimated the incidence of angiography-visible
falciform arteries as approximately 3% (unpublished data).
Preventive embolization of the HFA before TACE
remains controversial. Kim et al reported that 16 patients
with an HFA had no complications after chemoemboliza-
tion [6]. However, supraumbilical skin rash was reported
on several occasions [3,4,7–9]. Williams et al presented a
case with supraumbilical skin rash after intra-arterial chemo-
therapy [3]. The falciform artery was ligated and chemo-
therapy for the patient was resumed without incident.
The HFA and the subcutaneous artery can be anas-
tomosed directly or via the ensiform branch of the internal
thoracic artery [8,10]. An enlarged falciform artery may be
Figure 1. Arterial phase of the left hepatic arteriogram showing one
hypervascular stain (arrowhead) at S4 and a dilated falciform artery
(arrow) arising from the left hepatic artery.
Figure 2. Painful skin induration in the supraumbilical region.
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associated with adhesions around the HFA after laparotomy
or with stenosis/occlusion of the hepatic artery [3,7]. In our
case, focal excision of bilateral breast fibromas and previous
abdominal total hysterectomy may have interrupted the
network between the HFA and the superior epigastric
artery/internal thoracic artery, enlarging the HFA. Thus,
the infusion of chemotherapeutic agents through the HFA
may be the likely cause of the skin rash. Microscopic findings
of fat necrosis with foreign body reaction in this lesion
supported this proposal.
We propose that the hemodynamic state between
communication of the falciform artery and the internal
thoracic artery/superior epigastric artery may be the key
factor as to whether a supraumbilical skin rash may occur.
Figure 3. (A) Axial computerized tomography (CT) image with contrast enhancement 1 month after transcatheter arterial chemoembolization
(TACE) shows thickening of the supraumbilical skin (arrowhead) associated with increased-density subcutaneous fat (arrow). (B) Axial CT image
obtained 7 cm cranial to that in (A). The connective tissue along the falciform ligament (arrows) is expanded with infiltration and the left hepatic
lobe is downwardly displaced. (C) Axial CT image with contrast enhancement 3 months after TACE. Interval shrinkage of the affected skin area
(arrowhead) and a subcutaneous high-density nodule are evident. (D) Axial CT image with contrast enhancement 1 year after TACE. The
subcutaneous high-density nodule measures about 2 × 2.6 × 2.7 cm. The supraumbilical skin remains thickened but is significantly decreased in
surface area.
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If the falciform artery cannot be left out of the chemo-
embolization and the previous medical history suggests
possible enlargement of the HFA, we recommend preven-
tive falciform artery embolization to avoid skin complica-
tions.
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